This trial aims at improving end of life care for heart failure patients. To participate you need to be a patient or carer who has experienced end of life conversations with their doctor or nurse due to issues of heart failure. See all of our trials 👉 l.ead.me/ct-p-tw

Wondering why His Majesty’s Passport Office are changing applications from electronic to paper. Do they not have enough computers to deal with backlog?

Empagliflozin reduced the incidence of hyperkalaemia without significant increase in hypokalaemia in an analysis from EMPEROR-Pooled: read more in EHJ! doi.org/10.1093/eurhea… European Society of Cardiology European Society of Cardiology Journals

#REVIVED trial - #PCI for Ischaemic Ventricular Dysfunction #PCI did not reduce the composite incidence of all-cause ☠️ or hospitalisation for #HeartFailure at a median of 3.4 years #ESCCongress #HeartFailure #CAD European Society of Cardiology Journals European Society of Cardiology Mamas A. Mamas Less-Is-More Cardiologist PCRonline 🫀

Many of my nursing and healthcare colleagues are waking up to this. Currently too scared to look at my payslip suspect it’s too late for us to ask for a time to pay arrangement…